Cost-effectiveness of Mavacamten for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy using a French healthcare perspective

Authors: F-E Cotté, M Hurst, S Akarkoub, M Ho, J Vernon, L Chambry, S Leproust

Published: The European journal of health economics : HEPAC : health economics in prevention and care, 2025